Chimera Bioengineering

Chimera Bioengineering

Chimera Bioengineering

Chimera's mission is to reprogram life to end cancer, using therapies that restore dignity to patients. We do this with next generation, safer and more potent, CAR T therapeutics.
Type
B2b
Founded
2015
Follow us
Alexa global traffic share
Latest funding
Undisclosed amount
Seed fund - 2017
Kairos Venture Investments
Team Size
2
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Chimera Bioengineering makes some noise.